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Sensitivity to oxazolone induced 
dermatitis is transferable with gut 
microbiota in mice
Line Fisker Zachariassen1, Lukasz Krych2, Kåre Engkilde3, Dennis Sandris Nielsen2, 
Witold Kot4, Camilla Hartmann Friis Hansen1 & Axel Kornerup Hansen1
Atopic Dermatitis (AD) has been associated with gut microbiota (GM) dysbiosis in humans, indicating 
a causative role of GM in AD etiology. Furthermore, the GM strongly correlates to essential disease 
parameters in the well-known oxazolone-induced mouse model of AD. Here, we demonstrate 
that it is possible to transfer both a high-responding and a low-responding AD phenotype with GM 
from conventional mice to germ-free mice. The mice inoculated with the high-responding GM had 
significantly higher clinical score, increased ear thickness, and increased levels of IL-1β, TNFα, IL-4, 
IL-5, and IL-6 compared to the mice inoculated with the low-responding GM. The inter-individual 
variation was in general not affected by this increase in effect size. Germ-free mice induced with 
AD revealed a high disease response as well as high inter-individual variation indicating protective 
properties of certain microbial taxa in this model. This study underlines that the GM has a strong impact 
on AD in mouse models, and that the power of studies may be increased by the application of mice 
inoculated with a specific GM from high responders to increase the effect size.
Atopic dermatitis (AD) is a common skin disease characterized by inflammatory, noncontagious, pruritic 
eczema1. AD is driven by contact with environmental allergens, which often in their form of haptens become 
immunogenic when reacting with host proteins. Pathogenesis includes skin barrier disruption, genetic predis-
position2, elevated IgE levels and immune dysregulation characterized by initial T helper cell type 2 (Th2) and T 
helper cell type 1 (Th1) in the chronic phase3–5.
Stress, infections, and exposure to food- and aeroallergens all contribute to the disease6,7. The hygiene hypoth-
esis proposed by Strachan in 1989, postulates that a decreased exposure to bacteria early in life due to increased 
hygiene in the Western industrialized countries results in impaired immune system activation and regulation 
leading to higher prevalence of allergies and atopic diseases8,9. This could explain the higher prevalence of AD in 
Western industrialized countries being more sanitized than developing countries10–12.
Human studies have revealed gut microbiota (GM) compositional changes in AD patients compared to 
healthy controls. In general, patients with AD have a less diverse GM, with a lower abundance of Bifidobacterium 
spp. while being more frequently colonized with Staphylococcus aureus, certain clostridia, and Escherichia coli13–15. 
The amount of E. coli in the GM further correlates to serum IgE concentrations16. Bifidobacterium spp. has an 
alleviating effect, showing a positive effect of probiotics in both prevention and treatment of AD17–19. GM com-
position changes are demonstrated early in life prior to any clinical manifestations, indicating that dysbiosis is 
causative rather than an effect of AD20,21.
A well-known model for AD-like symptoms is the oxazolone-induced mouse, in which multiple epicutaneous 
administration of oxazolone, a potent hapten, induces a chronic Th2 hypersensitivity reaction resembling the 
features of initial human AD. Clinically, this model is characterized by a thickened ear/oedema, haemorrhagia, 
excoriations, and lichenefication22,23. In this model, the GM has shown to strongly correlate with ear tissue levels 
of IFN-γ , TNF-α , and IL-1024.
Previously, a causal relationship between GM and obesity25, colitis26 and enteric infections27 has been 
demonstrated by fecal transfer of phenotypes to germ-free mice. However, it has never been demonstrated that 
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sensitivity to chronic oxazolone inflammation, resembling AD, can be transferred with the GM between mice. 
This is of fundamental interest, as it will indicate a causal role of GM in AD and provide an excellent model for 
identifying protective or AD enhancing bacteria. Furthermore, from an animal model perspective, effect size and 
study power may be increased if mice prior to induction are inoculated with a GM yielding a stronger AD resem-
bling phenotype. Finally, it is of interest to know, whether transfer of a GM from a high responder will increase 
the Th2 response on the cost of a Th1 response, thereby making the oxazolone model more translational to the 
initial Th2 dominated response in human AD28.
We, therefore, hypothesized that both a high and a low responding oxazolone phenotype can be transferred 
from conventional mice with the GM to germ-free mice, and that germ-free mice differ in disease sensitivity from 
conventional mice.
Material and Methods
Ethics. The experiments were carried out in accordance with the Danish Act on Animal experimentation 
(LBK nr 474 of 15/05/2014), which implements the directive 2010/63/EU on the protection of animals used 
for scientific purposes. The study was approved by the Animal Experimentation Inspectorate, Ministry of 
Environment and Food, Denmark (license No. 2012-15-2934-00399) and health monitoring was performed 
according to FELASA guidelines29.
Animals. C57BL/6Ntac mice (n = 16, 7wks) (Taconic, Lille Skensved, Denmark) allowed to acclimate for 1 
week were housed in our AAALAC accredited barrier protected facility (Faculty of Health and Medical Sciences, 
University of Copenhagen, Frederiksberg, Denmark) in open cages without filter lids with free access to an 
Altromin 1324 diet (Brogaarden, Lynge, Denmark) and tap water.
Nine germ-free C57BL/6Ntac (6 females, 3 males, 7wks) (Taconic, Germantown, NY) were housed in our 
AAALAC accredited germ-free facility (Faculty of Health and Medical Sciences, University of Copenhagen, 
Frederiksberg, Denmark) in HEPA-ventilated isolators (PFI systems, Milton Keynes, UK) (pressure 110 pascal, 
23 °C) with free access to an irradiated Altromin 1324 diet (Brogaarden) and sterile water. Germ-free status was 
tested both by culturing and PCR methods30. DNA extractions was made with the mobio Powerlyzer Powersoil 
DNA isolation kit (Mo bio laboratories, inc., Carlsbad, CA) following manufactures instructions.
First, dermatitis was induced on the ears of all the barrier housed (CONV) mice. Based upon an overall 
evaluation of the dermatitis score, ear thickness, and concentrations of IFN-γ, IL-10, IL-1β, IL-2, IL-5, IL-6, and 
TNF-α, a high and low-responding donor were selected (Table S1). Next, feces from the donors was suspended 
in phosphate-buffered saline and given by oral gavage to pregnant germ-free dams in two different isolators, and 
subsequently the off-spring of these (n = 13) (HIGH and LOW mice) as well as germ-free off-spring (n = 12) in a 
third isolator was used for induction of dermatitis as done for the CONV group (Fig. 1).
Induction of skin inflammation. All mice (8wks), were sensitized once with 0.8% (w/v) 
4-ethoxymethylene-2-phenyl-2-oxazolin-5-one (Oxazolone)(Sigma-Aldrich, St. Louis, MO, USA) dissolved 4:1 
in acetone (Emsure, MerckChemicals, Germany) and olive oil (Organic extra virgin olive oil, Svansø, Denmark) 
with a pipette on both sides of the right ear. After one week the mice were challenged on days 0, 3, 7, 10, 12, 14, 16, 
18 and 20 with a fresh solution of 0.4% (w/v) oxazolone dissolved in acetone and olive oil 4:1 on both sides of the 
Figure 1. Study setup. Germ-free C57BL/6 dams in three different isolators were inoculated with fecal gut 
microbiota from the lowest responding conventional mouse (LOW), the highest responding conventional 
mouse (HIGH) or not inoculated at all. The off-spring of the inoculated dams develops oxazolone induced 
dermatitis on the ears at the age of eight weeks.
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right ear. All mice were sacrificed and sampled on day 21. The dosage of oxazolone was based upon an in-house 
pilot study as well as a previous study showing correlations between the GM and ear tissue concentrations of 
inflammatory cytokines in the oxazolone model24.
Clinical Scores. At euthanasia the inflamed ear was macroscopically scored blindly by two independent per-
sons for each of the signs 1) flare haemorrhage, 2) oedema, 3) excoriation and erosion, and 4) incrustation and 
xerosis as follows: 0 = no sign; 1 = mild; 2 = moderate; or 3 = severe31 adding the sum of the mean between the 
two scores as the total dermatitis score. Ear thickness was recorded on day 21 by using a micrometer (Mitutoyo 
Low Force Caliper Series 573, Aurora, Illinois); each measurement was repeated twice and the calculated mean 
used. The same person performed all measurements to ensure similar pressure and placement of the micrometer.
Serum IgE. Orbital blood was collected terminally under anesthesia with 25% Hypnorm (Fentanyl/Fluanison, 
Vetapharma, Leeds, UK) and 25% Midazolam Hameln (5 mg/ml, Matrix Pharmaceuticals, Hellerup, Denmark) 
0.1 ml pr. 10 g BW. Serum IgE concentration was determined in a 1:20 dilution with the mouse IgE ELISA kit from 
Bethyl Laboratories (Montgomery, TX), following manufacturer’s instructions.
Ear tissue cytokines. An 8 mm biopsy punch (Kruuse, Langeskov, Denmark) from the inflamed ear 
was frozen in liquid nitrogen and stored at − 80 degrees. The day of analysis, the ear tissue was thawed on ice 
and homogenized in 300 μ l lysis buffer (stock solution contained 10 ml Tris lysis buffer (Mesoscale Discovery, 
Rockville, MD), 100 μ l phosphatase inhibitor 1, 100 μ l phosphatase inhibitor 2 and 200 μ l protease inhibitor (MSD 
inhibitor pack, Mesoscale Discovery)) using a tissue blender (Polytron® PT 1200 E, Kinematica AG, Lucerne, 
Switzerland). The homogenized tissue was centrifuged (7500 g; 5 min) and the supernatant used for analyzing 
the amount of IFNγ , IL1β , IL2, IL4, IL5, IL6, keratinocyte-derived chemokine/growth-related oncogene (KC/
GRO), IL10, IL12p70, and TNFα (Proinflammatory Panel 1 (mouse) kits, Vplex (Mesocale Discovery)) and IL-13 
(mouse IL-13 assay ultra-sensitive kit (Mesoscale Discovery)) according to manufactures instructions. Results 
were read on a MESO QuickPlex SQ 120 (Mesoscale Discovery).
High throughput sequencing of the gut microbiota. The fecal microbiota of all groups were deter-
mined using tag-encoded 16S rRNA gene (V3-V4-region) MiSeq-based (2 × 250 PE) (Illumina, San Diego, CA) 
high throughput sequencing. DNA extraction was made with mobio Powerlyzer Powersoil DNA isolation kit (Mo 
bio Laboratories). DNA storage conditions, sequencing library preparation and sequencing steps were conducted 
as previously described30.
The raw dataset containing pair-ended reads with corresponding quality scores were merged and trimmed 
using fastq_mergepairs and fastq_filter scripts implemented in the UPARSE pipeline setting minimum overlap 
length to 10 bp. The minimum length of merged reads was 250 bp. The max expected error E = 2.0, and first 
truncating position with quality score N ≤ 4. Dataset from chimeric reads purging and constructing de novo 
Operational Taxonomic Units (OTU) were conducted UPARSE pipeline32. The green genes (13.8) 16S rRNA gene 
collection was used as a reference database. Quantitative Insight Into Microbial Ecology (QIIME) open source 
software package (1.7.0, 1.8.0 and 1.9.1)33,34 was used for analysis.
Alpha and beta diversity analysis was performed as previously described using iterative subsampling (36,000 
reads/sample)35. Permanova (compare_categories.py, Qiime 1.8.0) and PermanovaG (the Generalized UniFrac 
R package; GUniFrac)36 were used to evaluate group differences using weighted, unweighted and generalized 
uniFrac37 distance matrices respectively. All distance matrices were generated based on rarefied (36,000 reads/
sample) OTU tables. The relative distribution of the genera registered was calculated for unified and summarized 
in the genus level OTU tables.
The G test of independence (q_test) and ANOVA determined respectively: qualitative (presence/absence) and 
quantitative (relative abundance) association of OTUs with given category. Parametric student’s t-test incorpo-
rated in group_significance script (QIIME v9.1) was used to test frequencies of species level OTUs between the 
“high” and the “low” categories. The probability (p-value) was calculated based on random subsampled OTU 
tables rarefied to 36,000 per sample.
GM correlation analysis. Correlations between disease parameters and genera relative abundance were 
verified with the Pearson’s product-moment correlation coefficient (QIIME 1.7.0), based on 1000 rarefied OTU 
tables unified to an equal number of reads per sample (36,000). Correlations still significant after randomly 
removing three subsequent observations were considered valid.
Statistics. GraphPad Prism version 6.03 (GraphPad Software, San Diego, CA) was used for statistical anal-
ysis, and p values less than 0.05 were considered significant. Differences were estimated by one-way ANOVA 
test with post hoc t-tests for multiple testing or by Kruskal-Wallis test with post hoc Mann-Whitney U-test for 
multiple testing for data that either did not follow Gaussian distributions or did not have equal variances in the 
groups. Brown-Forsythe’s test was used to compare differences in variances and ranges. Regressions on the cor-
relation between different parameters, the GM excluded, were made as fitted line plots in Minitab 17 (Minitab 
Ltd., Coventry, UK).
Results
In this study, we tried to transfer sensitivity to oxazolone induced dermatitis with the GM from a high and low 
responding donor to two groups of germfree mice. A third group of mice was kept germfree to investigate the role 
of bacteria in oxazolone induced dermatitis.
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Immunological parameters. We found that the most relevant cytokines for the oxazolone model were 
IL-1β , TNFα , IL-4, and IL-6, which shared more than 25% of their variation with the variation in ear thickness in 
all dermatitis induced mice (Fig. 2). For all of these cytokines, as well as IL-5, the HIGH mice had a higher level in 
ear tissue than the LOW mice. IL-1β , TNFα , IL-6 and KC/GRO were also higher in HIGH mice compared to the 
CONV mice, while all germfree derived mice (HIGH, LOW and germfree) had lower concentrations of IL-12p70 
compared to the CONV mice (Fig. 2). Data from IL-13 are not shown due to concentrations under detection level 
of the assay.
Generally, the CONV mice had the lowest variation (TNF-α , KC/GRO) and the germ-free mice had the high-
est variation (IL-1β , IL-4, IL-6). The inter-individual variation was not lowered in the HIGH and LOW mice 
inoculated with a uniform GM (Table S2).
Clinical parameters and serum IgE concentration. The LOW mice had lower dermatitis score com-
pared to all other groups which did not differ in dermatitis score (Fig. 3A). There were no significant differences 
in the size of the ranges between the groups (Table S2). The HIGH mice had thicker and the LOW mice had thin-
ner ears compared to both CONV and germ-free mice (Fig. 3B). The germ-free mice expressed a higher variation 
in ear thickness compared to the other groups (Table S2).
Germ-free mice had significantly higher levels and ranges of serum IgE compared to the other groups, in 
which no differences were evident (Fig. 3C and Table S2).
Gut microbiota upon transfer to germ-free mice. Sequences purged from chimeric reads yielded 
3,571,114 giving an average of 101,998 sequences per sample (min = 42,442; max = 223,427; SD = 43,185 with 
a mean sequence length of 451 bp (± 25 bp). Five samples were discarded due to low read number (< 300 reads). 
GM transfer resulted in two new GM profiles clearly different from each other and from the conventional mice 
Figure 2. Ear tissue cytokine concentrations. Graphs illustrate cytokine responses (pg/ml) with SD in ear 
tissue from mice with oxazolone induced dermatitis. CONV: Mice randomly selected from a conventionally 
barrier-protected colony. CONV mouse marked with ★ = Donor HIGH. CONV mouse marked with 
X = Donor LOW. LOW: Ex-germ-free mice inoculated with the gut microbiota from the lowest responding 
CONV mouse; HIGH: Ex-germ-free mice inoculated with the gut microbiota from the highest responding 
CONV mouse; Germfree: Germ-free mice. Highlights reflects the correlation to the clinical score ‘Ear 
Thickness’ (ET) with the adjusted correlation coefficient (cc) stated with the significance level, i.e. red highlight: 
cc > 35%; yellow highlight: cc > 25%; green highlight; cc ≥ 15%; blue highlight: cc < 15%; no highlight: not 
significant. Significance lines indicate differences between means of all groups compared by ANOVA with 
subsequent t-tests for data with equal variances and by Kruskall-Wallis and Mann-Whitney test for data not 
showing equal variances. Data from IL-13 is not shown due to concentrations under detection level of the assay. 
*p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001.
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(Fig. 4A,B and C). The CONV and HIGH mice had comparable alpha diversity indexes, while the LOW mice had 
significantly lower diversity compared to CONV and HIGH according to observed species and chao1 indexes 
(p < 0.01), while the LOW Shannon diversity index was only significantly lower compared to CONV (p < 0.01)
(Fig. 5). This difference was mostly due to the LOW mice missing a number of Clostridiales assigned OTUs. The 
HIGH mice did not harbor the specific murine bacterium Mucispirillum schaedleri (Table 1).
The community level differences in relative abundance between CONV, HIGH and LOW groups (Fig. 4B) 
were also reflected in the relative abundance of several OTUs being significantly different between the groups. 
Noticeable differences are that the HIGH and LOW mice had a lower abundance of unclassified species belonging 
to the families of Bacteroidales S24-7 and Lachnospiraceae and higher abundance of Lactobacillus spp. compared 
to the CONV mice (Table 2A). When comparing the GM of LOW and HIGH mice alone, the GM of HIGH mice 
was to a higher degree dominated by species belonging to the family of Lachnospiraceae, as well as Bacteroides 
Figure 3. Dermatitis score, Ear thickness and Serum IgE concentration. Graphs illustrate median and range 
for Total dermatitis score (A) and mean and standard deviation for ear thickness (B; mm) from ears as well 
as serum IgE (C; ng/ml) of mice with oxazolone induced dermatitis. CONV: Mice randomly selected from a 
conventionally barrier-protected colony. CONV mouse marked with ★ = Donor HIGH. CONV mouse marked 
with X = Donor LOW; LOW: Ex-germ-free mice inoculated with the gut microbiota from the lowest responding 
CONV mouse; HIGH: Ex-germ-free mice inoculated with the gut microbiota from the highest responding 
CONV mouse; Germfree: Germ-free mice. Significant lines indicate differences between means of all groups 
compared by ANOVA with subsequent t-tests for data with equal variances and by Kruskall-Wallis and Mann-
Whitney test for data not showing equal variances. Differences in dermatitis score (A) is calculated by Kruskall-
Wallis and Mann-Whitney test. *p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001.
Figure 4. PCoA plots of gut microbiota clustering. Projection of differences in the gut microbiota 
composition between mice with oxazolone induced dermatitis. CONV: Mice randomly selected from a 
conventionally barrier-protected colony; LOW: Ex-germ-free mice inoculated with the gut microbiota from the 
lowest responding SPF mouse (marked with a green circle); HIGH: Ex-germ-free mice inoculated with the gut 
microbiota from the highest responding CONV mouse (marked with a green square); Germfree: Germ-free 
mice. PCoA plots based on unweighted (A), weighted (B) and generalised UniFrac distance matrices calculated 
from 10 rarefied (36,000 reads/sample) OTU tables. Group differences between the three categories were based 
on PermanovaG.
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uniformis and an unclassified genus of Rikenellaceae (Table 2B). In contrast, the LOW mice tended to have more 
unclassified Bacteroides spp. compared to the HIGH mice (p = 0.008, FDR = 0.059).
These differences evident between the inoculated groups were not present in the donor mice, in which there 
was no difference in the occurrence or abundance of Lachnospiraceae spp., Bacteroides spp., Rikenellaceae spp. 
or M. schaedleri (Table S3). The LOW donor seemed to have a lower abundance of Lactobacillus compared 
to the HIGH donor. This was opposite in the colonized groups in which the LOW mice tended to have more 
Lactobacillus than the HIGH mice. However, a pronounced abundance of Lactobacillus is evident in both the 
colonized groups (Table 2A).
The relative abundance of several species correlated with various clinical and immunological parameters. Even 
after random removal of a data point three times, significant correlations, mostly within the phylum Firmicutes, 
were found (Figure S1). Most strikingly, ear thickness in CONV mice showed a strong correlation to Mollicutes 
spp., Enterococcus spp., and Mucispirillum spp.
Discussion
The HIGH and the LOW phenotypes from the conventional mice were clearly transferred to germ-free mice, as 
there was a higher expression of dermatitis score, ear thickness, IL-1β , TNFα , IL-4, and IL-6 in the HIGH mice 
compared to the LOW mice, and for most of these also higher than the CONV mice. GM transfer in general had 
very little impact on inter-individual variation within the groups in this model. However, the germ-free mice had 
the highest variation in ear thickness, IgE, IL-1β , TNFα , IL-4, and IL-6, so most likely GM secures a uniform 
response in these parameters. In study designs, group sizes may be reduced by using tailor-made mice inoculated 
with a high responder GM due to the increased clinical effect size.
The strong correlation between macrophage produced cytokines IL-1 β 38, TNFα 39, and IL-640 and ear thick-
ness indicate a GM impact on macrophage activity with subsequent impact on inflammation and T-cell prolif-
eration. The IL-1β augmented TNFα signaling due to up-regulation of TNFα secretion and surface receptor 
expression in macrophages is triggered by Gram negative bacterial wall lipopolysaccharides (LPS)41, and is an 
important part of antimicrobial immunity42. IL-4 from Th2 cells43 induce IgE isotype switch in B-cells44, which is 
closely linked to atopic allergy diseases45,46. GM transfer therefore seems to increase T cell responses in the HIGH 
mice, and their increased level of the Th2 cytokine IL-543 indicates a higher Th2 response. Moreover, IL-1β , highly 
correlating with ear thickness, promotes the formation of IL-17 producing Th17 cells47; a key element in the Th2 
activation in AD in mice48. The low level of IL12p70 in GM transplanted mice indicates that the role of Th1 cells 
was decreased by GM transfer. IgE responses did not seem to differ between neither the mice with different GM, 
nor in the donor mice. Interestingly, germ-free mice had a much higher and more varying IgE production com-
pared to all colonized mice strongly supporting the protective role of bacteria in type 1 hypersensitivity reactions 
known from other murine allergy models49,50.
Neither the GM of HIGH, nor LOW mice clustered with their donors. GM transfer dramatically increased 
the relative abundance of Firmicutes; primarily due to an increase in Lactobacillus spp. Previously, we found 
that when germ-free mice were inoculated at weaning they clustered with the inoculum later in life, but we also 
showed that timing of inoculation is important for transferring GM profiles51. It is, however, likely that there will 
be changes in the GM, when the mothers are inoculated, when the offspring are born, and over time from birth to 
termination that could explain why clustering is not observed between inoculum and recipients. Further, it can-
not be ruled out that short exposure to oxygen during transfer, influences the inoculum giving oxygen-tolerant 
species such as Lactobacillus spp. a competitive advantage when the GM of the inoculated mice is established.
Remarkably, germ-free mice responded highly in key parameters, such as total dermatitis score, ear thickness, 
TNFα , IL-4, and IL-5. As the LOW mice had the lowest GM diversity compared to HIGH and CONV mice, the 
high response of the germ-free mice indicates a GM impact on AD in mice to be a question of the presence of 
protective bacteria rather than a question of diversity. Bacteria present in the LOW mice in contrast to the HIGH 
mice (Table 1) were M. schaedleri, Blautia producta and an unclassified species of Erysipelotrichaceae. None of 
Figure 5. Diversity indexes. Rarefaction curves based on observed species index (97% sequence similarity 
threshold), Chao1 and Shannons diversity index. Alpha diversity measure expressed with observed species 
and chao1 indexes revealed significantly reduced (p < 0.01) diversity in ex-germ-free mice inoculated with the 
gut microbiota from the lowest responding CONV mouse (LOW) compared to ex-germ-free mice inoculated 
with the gut microbiota from the highest responding CONV mouse (HIGH) as well as to barrier protected 
mice (CONV). Shannon diversity index only revealed a reduced (p < 0.01) diversity in LOW mice compared to 
CONV mice. **p < 0.01.
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these are known for specific protecting roles against AD. M. schaedleri of the Deferribacteres phylum is not found 
in the human gut, but it may in mice have abundance up to 1%, and it has been used for decades as a member of 
the altered Schaedler flora (ASF 457)52–54. However, in the CONV mice there was a strong positive correlation 
between the abundance of M. schaedleri and ear thickness, so it is not the most likely AD-protecting candidate.
The two colonized groups differed in the relative abundance of a range of bacteria. For example, 
Lachnospiraceae spp. was more abundant in the HIGH mice, which may increase AD response, as children suf-
fering from AD tend to have a higher abundance of Clostridia14,21,55. On the other hand, LOW mice showed a 
tendency to have a higher abundance of Lactobacillus spp., which was only significant if a general outlier in the 
LOW group was removed (p = 0.039 with outlier removed), and Lactobacillus spp. may have a possible protective 
effect against AD, as previous studies have shown that different species of dietary Lactobacillus may relieve AD 
symptoms in murine models56–60.
LOW mice compared to HIGH mice showed a tendency (p = 0.008, FDR-corrected p = 0.059) for higher 
abundance of the genus Bacteroides, which may have a preventive effect, as a previous study has shown that 
Bacteroides fragilis is anti-inflammatory and contributes to development of host immunity61. Further, mono-
colonization with B. fragillis lowered the amount of IL-4 production from CD4+ T cells in germ-free mice62. 
Therefore, the lower concentration of IL-4 in the LOW mice could be mediated by the higher abundance of 
Bacteroides. Compared to the LOW mice, HIGH mice showed a greater abundance of another Bacteroides frac-
tion identified as Bacteroides uniformis. Administration of B. uniformis has been shown to ameliorate obesity 
and the associated immune alteration63. Obesity is Th1 dominated64, in contrast to the Th2 dominated AD3–5. 
Consequently, the higher abundance of B. uniformis in the HIGH mice may alter the Th1/Th2 balance, thereby 
contributing to Th2 predominance in the HIGH mice.
This study shows that the expression of oxazolone induced dermatitis in mice can be influenced solely by 
GM interventions. As mentioned in the introduction, patients with AD have compositional changes in their 
GM13–16,21, which indicates that GM intervention as treatment or prevention strategy could have an alleviating 
effect on AD. GM intervention would be a good alternative to the present treatment of AD, which now comprises 
mainly of topical corticosteroids, which can cause adverse skin side effects65.
The diet has been shown to be an important driver of GM composition and function66–68, so a dietary inter-
vention could be a possible and easy accessible approach to change the GM in patients with AD, resembling that 
of healthy individuals. A more complicated, yet possible, method is fecal transplantation from healthy individuals 
phylum class order family genus species
significantly 
different 
after FDR 
correction
Number of species level OTUs with significantly skewed distribution in:
CONV LOW HIGH
more than 
expected
less than 
expected
more than 
expected
less than 
expected
more than 
expected
less than 
expected
Bacteroidetes Bacteroidia Bacteroidales S24-7 Unclassified Unclassified 102 90 12 17 85 36 66
Deferribacteres Deferribacteres Deferribacterales Deferribacteraceae Mucispirillum schaedleri 1 1 0 1 0 0 1
Firmicutes Bacilli Lactobacillales Lactobacillaceae Lactobacillus Unclassified 61 0 61 61 0 59 2
Firmicutes Clostridia Clostridiales Lachnospiraceae Blautia producta 1 0 1 1 0 0 1
Firmicutes Clostridia Clostridiales Lachnospiraceae Blautia Unclassified 2 2 0 0 2 2 0
Firmicutes Clostridia Clostridiales Lachnospiraceae Coprococcus Unclassified 2 2 0 0 2 1 1
Firmicutes Clostridia Clostridiales Lachnospiraceae Lachnobacterium Unclassified 1 1 0 0 1 0 1
Firmicutes Clostridia Clostridiales Lachnospiraceae Ruminococcus gnavus 12 10 2 0 12 12 0
Firmicutes Clostridia Clostridiales Lachnospiraceae Unclassified Unclassified 145 100 45 13 132 114 31
Firmicutes Clostridia Clostridiales Peptococcaceae rc4-4 Unclassified 1 1 0 0 1 0 1
Firmicutes Clostridia Clostridiales Ruminococcaceae Ruminococcus Unclassified 2 2 0 0 2 0 2
Firmicutes Clostridia Clostridiales Ruminococcaceae Unclassified Unclassified 5 5 0 0 5 1 4
Firmicutes Clostridia Clostridiales Unclassified Unclassified Unclassified 296 223 73 87 209 166 130
Firmicutes Erysipelotrichi Erysipelotrichales Erysipelotrichaceae Unclassified Unclassified 1 1 0 1 0 0 1
Tenericutes Mollicutes Anaeroplasmatales Anaeroplasmataceae Anaeroplasma Unclassified 1 1 0 0 1 0 1
Table 1.  G test showing the qualitative (presence/absence) association of Operational Taxonomic 
Units (OTU). Compilation of the g test results based on the subsampled (36,000 reads/sample) species level 
OTUs in conventional (CONV), as well as ex-germ-free mice inoculated with gut microbiota from either a 
high responder (HIGH) or a low responder (LOW) in relation to atopic dermatitis. In total 633 OTUs were 
significantly associated with one of three categories. All those OTUs could be categorized into 15 taxonomic 
groups presented in the table. For example (firs row): In total 102 OTUs, all representing S24-7 family, presented 
significantly skewed distribution between the three categories. 90 of these OTUs were overrepresented (more 
than expected) within the SPF category, while 12 remaining OTUs were underrepresented in this group etc. The 
False Discovery Rate (FDR) represents the probability after correction with FDR where the raw p-values are 
firstly ranked from low to high and then each p-value is multiplied by the number of tests divided by this rank. 
Taxa denoted as “unclassified” means that the reference database does not have an official taxonomy for this 
cluster. Taxa denoted as “Other” indicates ambiguity in the assignment meaning that more than one taxon could 
be assigned to this cluster at given taxonomic level.
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to patients with AD. Fecal transplantation has recently shown to be effective against other GM associated diseases 
e.g. Inflammatory Bowel Disease69–71 and Clostridium difficile infection72, so it is not unlikely that it could influ-
ence the expression of AD. The effect of fecal transplantation may decrease over time in a certain fraction of the 
patients, e.g. as observed for ulcerative colitis73, but since AD is considered a childhood disease, where symptoms 
often diminish in adulthood, this will most likely be a minor problem. Before fecal transplantation can be an 
option for treatment of AD, it would require much more research to identify biomarkers and protective bacteria 
to find the optimal donors.
In conclusion, a high and a low responding phenotype of AD can be transferred with the GM to germ-free 
mice. The use of a high responding donor improves the applicability of the inoculated mice as models, because 
they develop increased ear thickness, higher IL-1β , and TNFα concentrations in ear tissue, as well as a more Th2 
dominated response.
phylum class order family genus species p value FDR HIGH %
LOW 
% CONV %
(A)
Actinobacteria Coriobacteriia Coriobacteriales Coriobacteriaceae Adlercreutzia Unclassified 0.00109 0.00638 0.01 0.01 0.03
Bacteroidetes Bacteroidia Bacteroidales Bacteroidaceae Bacteroides uniformis 0.00398 0.01266 0.08 0.02 0.06
Bacteroidetes Bacteroidia Bacteroidales Rikenellaceae Unclassified Unclassified 0.01223 0.02853 0.03 0.01 0.05
Bacteroidetes Bacteroidia Bacteroidales S24-7 Unclassified Unclassified 0.01288 0.02817 15.50 11.11 25.86
Firmicutes Bacilli Lactobacillales Lactobacillaceae Lactobacillus Other 0.00116 0.00580 0.70 0.38 1.87
Firmicutes Bacilli Lactobacillales Lactobacillaceae Lactobacillus reuteri 0.00684 0.01710 1.27 0.65 2.62
Firmicutes Bacilli Lactobacillales Lactobacillaceae Lactobacillus Unclassified 0.00009 0.00104 43.09 64.21 12.93
Firmicutes Clostridia Clostridiales Clostridiaceae Unclassified Unclassified 0.01893 0.03313 0.01 0.01 0.02
Firmicutes Clostridia Clostridiales Dehalobacteriaceae Dehalobacterium Unclassified 0.02601 0.04335 0.01 0.00 0.02
Firmicutes Clostridia Clostridiales Lachnospiraceae [Ruminococcus] gnavus 0.00306 0.01071 1.89 0.29 1.22
Firmicutes Clostridia Clostridiales Lachnospiraceae Blautia Unclassified 0.00019 0.00162 0.05 0.00 0.01
Firmicutes Clostridia Clostridiales Lachnospiraceae Coprococcus Unclassified 0.00056 0.00390 0.14 0.04 0.25
Firmicutes Clostridia Clostridiales Lachnospiraceae Dorea Unclassified 0.01843 0.03395 0.00 0.00 0.00
Firmicutes Clostridia Clostridiales Lachnospiraceae Other Other 0.00236 0.00919 0.41 0.09 0.89
Firmicutes Clostridia Clostridiales Lachnospiraceae Roseburia Unclassified 0.01474 0.02867 0.01 0.00 0.00
Firmicutes Clostridia Clostridiales Lachnospiraceae Unclassified Unclassified 0.00141 0.00615 13.25 2.76 13.77
Firmicutes Clostridia Clostridiales Other Other Other 0.00415 0.01211 0.79 0.24 1.69
Firmicutes Clostridia Clostridiales Peptococcaceae rc4-4 Unclassified 0.00003 0.00052 0.09 0.05 0.20
Firmicutes Clostridia Clostridiales Ruminococcaceae Unclassified Unclassified 0.00003 0.00097 0.48 0.25 1.00
Tenericutes Mollicutes RF39 Unclassified Unclassified Unclassified 0.00427 0.01149 0.00 0.00 0.02
phylum class order family genus species p value FDR HIGH % LOW %
(B)
Bacteroidetes Bacteroidia Bacteroidales Bacteroidaceae Bacteroides uniformis 0.00110 0.02919 0.07 0.02
Bacteroidetes Bacteroidia Bacteroidales Rikenellaceae Unclassified Unclassified 0.00204 0.03001 0.03 0.01
Firmicutes Clostridia Clostridiales Lachnospiraceae [Ruminococcus] gnavus 0.00325 0.03227 1.89 0.30
Firmicutes Clostridia Clostridiales Lachnospiraceae Blautia producta 0.00365 0.03227 0.00 0.01
Firmicutes Clostridia Clostridiales Lachnospiraceae Blautia Unclassified 0.00097 0.02919 0.05 0.00
Firmicutes Clostridia Clostridiales Lachnospiraceae Unclassified Unclassified 0.00227 0.03001 13.27 2.78
Bacteroidetes Bacteroidia Bacteroidales Bacteroidaceae Bacteroides Unclassified 0.00782 0.05918 0.43 1.15
Firmicutes Clostridia Clostridiales Lachnospiraceae Unclassified Unclassified 0.01148 0.07384 0.41 0.09
Firmicutes Clostridia Clostridiales Lachnospiraceae Roseburia Unclassified 0.01254 0.07384 0.01 0.00
Firmicutes Clostridia Clostridiales Unclassified Unclassified Unclassified 0.03022 0.16014 0.80 0.25
Firmicutes Clostridia Clostridiales Lachnospiraceae Coprococcus Unclassified 0.03533 0.17024 0.15 0.04
Firmicutes Clostridia Clostridiales Dehalobacteriaceae Dehalobacterium Unclassified 0.04211 0.186 0.01 0.00
Table 2. Differences in relative abundance of given OTU (97% sequence similarity). CONV: Mice randomly 
selected from a conventionally barrier-protected colony. LOW: Ex-germ-free mice inoculated with the gut 
microbiota from the lowest responding CONV mouse; HIGH: Ex-germ-free mice inoculated with the gut 
microbiota from the highest responding CONV mouse analyzed with A) ANOVA and B) HIGH and LOW 
analyzed with parametric t-test. The p-value was calculated based on 1000 subsampled OTU tables rarefied to 
36,000 per sample. The False Discovery Rate (FDR) represents the probability after correction with FDR where 
the raw p-values are firstly ranked from low to high and then each p-value is multiplied by the number of tests 
divided by this rank. “Unclassified” stands for taxa having no official taxonomy in the database. Taxa denoted 
as “Other” indicates ambiguity in the assignment, meaning that more than one taxon could be assigned to this 
cluster at given taxonomic level. Taxa mentioned in the square brackets indicate a proposed taxonomy.
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